Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses

Journal of Biological Chemistry

Volumn 289, Issue 20, 2014, Pages 14283-14290

  Li, Hai Yun ^a   Wang, Jing ^a   Wu, Yue Xin ^a   Zhang, Lin ^a   Liu, Zu Pei ^a   Filep, János G ^b   Potempa, Lawrence A ^c   Wu, Yi ^a   Ji, Shang Rong ^a  

^a LANZHOU UNIVERSITY   (China)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c ROOSEVELT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CHEMICAL ACTIVATION; ENZYME INHIBITION; TISSUE; TOPOLOGY;

APICAL MEMBRANES; C-REACTIVE PROTEINS; ENDOTHELIAL CELL RESPONSE; EXPERIMENTAL CONDITIONS; HUMAN CORONARY ARTERIES; LIPID RAFT MICRODOMAINS; SIGNALING PATHWAYS; TOPOLOGICAL LOCALIZATION;

ENDOTHELIAL CELLS;

C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION; CHEMISTRY; CIRCULATION; CYTOLOGY; GENETICS; INFLAMMATION; METABOLISM; MUTATION; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TRANSPORT;

BLOOD CIRCULATION; C-REACTIVE PROTEIN; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; TYPE C PHOSPHOLIPASES;

EID: 84900992808     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.555318     Document Type: Article

References (37)

1. Pepys, M. B., and Hirschfield, G. M. (2003) C-reactive protein: a critical update. J. Clin. Invest. 111, 1805-1812
2. Singh, S. K., Suresh, M. V., Voleti, B., and Agrawal, A. (2008) The connection between C-reactive protein and atherosclerosis. Ann. Med. 40, 110-120
3. Allin, K. H., and Nordestgaard, B. G. (2011) Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab. Sci. 48, 155-170
4. Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., and Budoff, M. J. (2013) High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J. Am. Coll. Cardiol. 62, 397-408
5. Allin, K. H., Nordestgaard, B. G., Zacho, J., Tybjaerg-Hansen, A., and Bojesen, S. E. (2010) C-reactive protein and the risk of cancer: a Mendelian randomization study. J. Natl. Cancer Inst. 102, 202-206
6. Zacho, J., Tybjaerg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., and Nordestgaard, B. G. (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N. Engl. J. Med. 359, 1897-1908
7. Ma, X., Ji, S. R., and Wu, Y. (2013) Regulated conformation changes in C-reactive protein orchestrate its role in atherogenesis. Chinese Sci. Bull. 58, 1642-1649
8. Wang, M.-Y., Zhou, H.-H., Zhang, S.-C., Hui, F., Zhu, W., Su, H.-X., Guo, H.-Y., Li, X.-W., Ji, S.-R., and Wu, Y. (2014) Recurrent mutations at C-reactive protein promoter SNP position -286 in human cancers. Cell Res. 24, 505-508
9. Filep, J. G. (2009) Platelets affect the structure and function of C-reactive protein. Circ. Res. 105, 109-111
10. Eisenhardt, S. U., Thiele, J. R., Bannasch, H., Stark, G. B., and Peter, K. (2009) C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 8, 3885-3892
11. Molins, B., Peña, E., de la Torre, R., and Badimon, L. (2011) Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. Cardiovasc. Res. 92, 328-337
12. Ji, S. R., Wu, Y., Zhu, L., Potempa, L. A., Sheng, F. L., Lu, W., and Zhao, J. (2007) Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J. 21, 284-294
13. Eisenhardt, S. U., Habersberger, J., Murphy, A., Chen, Y. C., Woollard, K. J., Bassler, N., Qian, H., von Zur Muhlen, C., Hagemeyer, C. E., Ahrens, I., Chin-Dusting, J., Bobik, A., and Peter, K. (2009) Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ. Res. 105, 128-137
14. Mihlan, M., Blom, A. M., Kupreishvili, K., Lauer, N., Stelzner, K., Bergström, F., Niessen, H. W., and Zipfel, P. F. (2011) Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J. 25, 4198-4210
15. Wang, M. Y., Ji, S. R., Bai, C. J., El Kebir, D., Li, H. Y., Shi, J. M., Zhu, W., Costantino, S., Zhou, H. H., Potempa, L. A., Zhao, J., Filep, J. G., and Wu, Y. (2011) A redox switch in C-reactive protein modulates activation of endothelial cells. FASEB J. 25, 3186-3196
16. Khreiss, T., József, L., Potempa, L. A., and Filep, J. G. (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109, 2016-2022
17. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
18. Schwedler, S. B., Amann, K., Wernicke, K., Krebs, A., Nauck, M., Wanner, C., Potempa, L. A., and Galle, J. (2005) Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 112, 1016-1023
19. Muller, W. A., and Gimbrone, M. A., Jr. (1986) Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination. J. Cell Biol. 103, 2389-2402
20. Mehta, D., and Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367
21. Diehl, E. E., Haines, G. K., 3rd, Radosevich, J. A., and Potempa, L. A. (2000) Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am. J. Med. Sci. 319, 79-83
22. Habersberger, J., Strang, F., Scheichl, A., Htun, N., Bassler, N., Merivirta, R. M., Diehl, P., Krippner, G., Meikle, P., Eisenhardt, S. U., Meredith, I., and Peter, K. (2012) Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc. Res. 96, 64-72
23. de la Torre, R., Peña, E., Vilahur, G., Slevin, M., and Badimon, L. (2013) Monomerization of C-reactive protein requires glycoprotein IIb-IIIa activation: pentraxins and platelet deposition. J. Thromb. Haemost. 11, 2048-2058
24. Motie, M., Schaul, K. W., and Potempa, L. A. (1998) Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice. Drug Metab. Dispos. 26, 977-981
25. Ji, S. R., Ma, L., Bai, C. J., Shi, J. M., Li, H. Y., Potempa, L. A., Filep, J. G., Zhao, J., and Wu, Y. (2009) Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J. 23, 1806-1816
26. Dunzendorfer, S., Lee, H. K., Soldau, K., and Tobias, P. S. (2004) Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18, 1117-1119
27. Triantafilou, M., Miyake, K., Golenbock, D. T., and Triantafilou, K. (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115, 2603-2611
28. Lauer, N., Mihlan, M., Hartmann, A., Schlötzer-Schrehardt, U., Keilhauer, C., Scholl, H. P., Charbel Issa, P., Holz, F., Weber, B. H., Skerka, C., and Zipfel, P. F. (2011) Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant. J. Immunol. 187, 4374-4383
29. Schwedler, S. B., Guderian, F., Dämmrich, J., Potempa, L. A., and Wanner, C. (2003) Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol. Dial. Transplant. 18, 2300-2307
30. Slevin, M., Matou-Nasri, S., Turu, M., Luque, A., Rovira, N., Badimon, L., Boluda, S., Potempa, L., Sanfeliu, C., de Vera, N., and Krupinski, J. (2010) Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol. 20, 151-165
31. Strang, F., Scheichl, A., Chen, Y. C., Wang, X., Htun, N. M., Bassler, N., Eisenhardt, S. U., Habersberger, J., and Peter, K. (2012) Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease? Brain Pathol. 22, 337-346
32. Ji, S. R., Wu, Y., Potempa, L. A., Liang, Y. H., and Zhao, J. (2006) Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26, 935-941
33. Mihlan, M., Stippa, S., Józsi, M., and Zipfel, P. F. (2009) Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ. 16, 1630-1640
34. Schwedler, S. B., Hansen-Hagge, T., Reichert, M., Schmiedeke, D., Schneider, R., Galle, J., Potempa, L. A., Wanner, C., and Filep, J. G. (2009) Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells. Clin. Chem. 55, 1728-1731
35. Ji, S. R., Wu, Y., Potempa, L. A., Qiu, Q., and Zhao, J. (2006) Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis. Int. J. Biochem. Cell Biol. 38, 648-661
36. Molins, B., Peña, E., Vilahur, G., Mendieta, C., Slevin, M., and Badimon, L. (2008) C-Reactive protein isoforms differ in their effects on thrombus growth. Arterioscler. Thromb. Vasc. Biol. 28, 2239-2246
37. Khreiss, T., József, L., Potempa, L. A., and Filep, J. G. (2005) Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ. Res. 97, 690-697